Key statistics
On Friday, Innoviva Inc (INVA:NSQ) closed at 21.80, -4.22% below its 52-week high of 22.76, set on Nov 13, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 21.56 |
|---|---|
| High | 21.92 |
| Low | 21.56 |
| Bid | 21.40 |
| Offer | 21.80 |
| Previous close | 21.57 |
| Average volume | 780.01k |
|---|---|
| Shares outstanding | 74.77m |
| Free float | 74.01m |
| P/E (TTM) | 16.71 |
| Market cap | 1.61bn USD |
| EPS (TTM) | 1.29 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
- Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea
- Innoviva to Participate in the 37th Annual Piper Sandler Healthcare Conference
